• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    104.18 1.73(1.69%) Jan 29, 4:00PM EST
    |Pre-Market : 105.00 Up 0.82 (0.79%) 6:22AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:102.45
    Open:102.41
    Bid:105.00 x 100
    Ask:105.39 x 300
    1y Target Est:122.58
    Beta:1.18
    Next Earnings Date: 3-Feb-15GILD Earnings announcement
    Day's Range:101.07 - 104.51
    52wk Range:63.50 - 116.83
    Volume:8,411,741
    Avg Vol (3m):17,208,700
    Market Cap:157.17B
    P/E (ttm):18.56
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 1.69%157.17B
    GSK108.56B
    PFE200.55B
    RHHBYN/A

    Key Statistics

    Forward P/E (1 yr):10.66
    P/S (ttm):7.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.90
    Quarterly EPS Est (Dec-14) :2.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback